Autologous stem cell transplantation in rheumatoid arthritis
John A. Snowden +12 more
openalex
Extramedullary Disease—Achilles Heel in Myeloma?
ABSTRACT Despite advances in therapy, extramedullary disease (EMD) remains an aggressive form of multiple myeloma associated with poor outcomes. Patients with true EMD, in which plasmacytomas have become completely independent of bone, have a particularly poor prognosis. The pathogenesis of EMD is driven by complex mechanisms involving loss of adhesion
Shaji Kumar +7 more
wiley +1 more source
Cautious Optimism Warranted for Stem Cell-Derived Islet Transplantation in Type 2 Diabetes
Hanne Scholz +4 more
doaj +1 more source
Case Report: autologous stem cell boost enables hematopoietic recovery after severe cytopenia induced by BCMA-targeted bispecific antibody therapy in multiple myeloma. [PDF]
Akiyama H +12 more
europepmc +1 more source
A Murine Bispecific Antibody Efficiently Redirects T Cells Against Calr Mutated Stem Cells In Vivo
ABSTRACT Calreticulin (CALR) mutations are prevalent in 20%–30% of patients with BCR::ABL1‐negative myeloproliferative neoplasms (MPN). Mutant calreticulin (mutCALR), presented by the thrombopoietin receptor (MPL, also known as TPOR or CD110) on the surface of the disease‐initiating MPN progenitors, represents an ideal target for curative ...
Shengen Xiong +5 more
wiley +1 more source
Rotation Restored: Fascia Lata Interposition for Proximal Radioulnar Synostosis after Olecranon Plating. [PDF]
Srikant K +5 more
europepmc +1 more source
This graphical abstract illustrates the research process regarding skin defect repair using a rat model of skin defect. First, it assesses whether the barrier function of the skin is repaired. If the answer is “YES”, the study proceeds to focus on structural repair.
Cong Sun +6 more
wiley +1 more source
Infection With Mycobacterium chelonae Following Autologous Facial Fat Grafting: A Case Report and Review of Literature. [PDF]
Alavi Darazam I +4 more
europepmc +1 more source
This review highlights how autoimmune diseases arise from intertwined immunological, genetic, and environmental factors, emphasizing gut microbiota dysbiosis as a pivotal driver. It outlines emerging nanotechnology‐based strategies—such as liposomes, hydrogels, and polymeric nanoparticles—that enhance targeted drug delivery, minimize systemic toxicity,
Md. Meraj Ansari +5 more
wiley +1 more source
Autologous profiling reveals inter-patient heterogeneity in Vδ2<sup>+</sup>γδTIL responses to glioblastoma driven by extracellular matrix-BTN3A axis. [PDF]
Nicolasen MJT +11 more
europepmc +1 more source

